Editas Medicine is a clinical stage genome editing company based in Cambridge, Massachusetts. Their focus is on developing transformative genomic medicines for serious diseases using a proprietary gene editing platform based on CRISPR technology. The company develops various treatments for multiple conditions such as inherited childhood blindness and sickle cell disease.